YD Bio Ltd (YDES)
YD Bio Ltd is a Taipei, Taiwan-based biopharmaceutical company listed on NASDAQ under the symbol YDES. The company focuses on blood-based cancer detection and is also developing stem cell- and exosome-based therapeutics aimed at addressing diseases with significant unmet medical needs. As a common stock security, YDES represents equity in the company rather than a fund or other specialized listed instrument.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-YDES
|
$4.65
|
-6.1% Downside
|
Fair
|
Not available
|
Not available
|
Weak
|
0.0%
|
December 1, 2026
|
1,146.7x
|
78.4x
|
282.9x
|
350.6 M
|
348 M
|
0.0%
|
22.9%
|
0.7
|
-2,846.0%
|
